We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toSpecial-Population-Study-Challenges

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Special Population Study Challenges

    Session Chair(s)
      William B. Smith, MD

      William B. Smith, MD

      • CEO
      • Alliance for Multispecialty Research/NOCCR, United States
    Early phase pharmacokinetic studies continue to be challenging. Current issues from regulatory, CRO/Sponsor, and site perspectives will be discussed and suggestions for optimizing protocols and operations will be presented.
    Learning Objective : Describe the design challenges of special population studies; Develop practical solutions to special population study obstacles.
      Charu  Gautam, MD

      Critical Challenges in Conducting PK Studies in Patients and Special Populations

      Charu Gautam, MD

      • Head- Early Clinical Development, Asia Pacific
      • IQVIA, India
      Harry  Alcorn, PharmD

      Special Population Studies: Thirty Years Experience Shared

      Harry Alcorn, PharmD

      • Chief Scientific Officer
      • DaVita Clinical Research, United States